Stop Superbugs Act funds clinical research on antibiotic resistance through grants.
The Stop Superbugs Act mandates the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant to the Antibiotic Resistance Leadership Group. This grant aims to establish a clinical research network focusing on antibiotic resistance. The network will support rapid recruitment of clinical trial participants, outreach in community settings, pairing diagnostic and pharmaceutical innovations during trials, and developing patient-reported outcomes in clinical studies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.